Effects of eicosapentaenoic acid on cardiovascular events in Japanese patients with hypercholesterolemia: Rationale, design, and baseline characteristics of the Japan EPA Lipid Intervention Study (JELIS)

American Heart Journal

Volumn 146, Issue 4, 2003, Pages 613-620

  Yokoyama, Mitsuhiro ^a   Origasa, Hideki ^b  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF TOYAMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ICOSAPENTAENOIC ACID; LONG CHAIN FATTY ACID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; POLYUNSATURATED FATTY ACID;

ADULT; AGE DISTRIBUTION; AGED; ANGIOPLASTY; ARTERY DISEASE; ARTICLE; CARCINOMA; CARDIOVASCULAR FUNCTION; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY STENT; DOSE RESPONSE; DRUG EFFICACY; DRUG PURIFICATION; EPIDEMIOLOGICAL DATA; FATALITY; FATTY ACID BLOOD LEVEL; FEMALE; FISH; FOLLOW UP; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HOSPITALIZATION; HUMAN; HYPERCHOLESTEROLEMIA; JAPAN; LIPID ANALYSIS; LIPID COMPOSITION; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; MORTALITY; OPEN STUDY; POSTMENOPAUSE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SINGLE BLIND PROCEDURE; STROKE; SUDDEN DEATH; UNSTABLE ANGINA PECTORIS;

EID: 0142025090     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(03)00367-3     Document Type: Article

References (35)

1. Dyerberg J, Bang HO, Stoffersen E. Eicosapentaenoic acid and prevention of thrombosis and atherosclerosis? Lancet 1978;2:117-9.
2. Oomen CM, Feskens EJ, Rasanen L. Fish consumption and coronary heart disease mortality in Finland, Italy, and The Netherlands. Am J Epidemiol 2000;151:999-1006.
3. Kromhout D, Bosschieter EB, de Lezenne Coulander C. The inverse relation between fish consumption and 20-year mortality from coronary heart disease. N Eng J Med 1985;312:1205-9.
4. Tamura Y, Hirai A, Terano T. Clinical and epidemiological studies of eicosapentaenoic acid (EPA) in Japan. Prog Lipid Res 1986;25:461-6.
5. Burr ML, Fehily AM, Gibert JK. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet 1989;2:757-61.
6. GISSI-Prevenzione Investigators. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevention trial. Lancet 1999;354:447-55.
7. Harris WS, Muzio F. Fish oil reduces pastprandial triglyceride concentrations without accelerating lipid-emulsion removal rates. Am J Clin Nutr 1993;58:68-74.
8. Wong SH, Fisher EA, March JB. Effects of eicosapentaenoic and docosahexaenoic acids on apoprotein B m RNA and secretion of very low density lipoprotein in HepG2 cells. Arteriosclerosis 1989;9:836-41.
9. Ando M, Sanaka T, Nihei H. Eicosapentaenoic acid reduces plasma levels of remnant lipoproteins and preventions in vivo peroxidation of LDL in dialysis patients. J Am Soc Nephrol 1999;10:2177-84.
10. Hirai A, Terano T, Hamazaki T. The effect of the oral administration of fish oil concentration on the release and the metabolism of [14C]arachidonic acid and [14C]eicosapentaenoic acid by human platelets. Thrombosis Res 1982;28:285-98.
11. Hamazaki T, Hirai A, Terano T. Effects of orally administered ethyl estel of eicosapentaenoic acid (EPA; C20: 5, omega 3) on PGI2-like substance production by rat aorta. Prostaglandins 1982;23:557-67.
12. Okuda Y, Kawashima K, Sawada T. Eicosapentaenoic acid enhances nitric oxide production by cultured human endothelial cells. Biochem Biophys Res Com 1997;232:487-91.
13. Marcmann P, Jespersen J, Leth T. Effect of fish diet versus meat diet on blood lipids, coagulation and fibrinosis in healthy young men. J Intern Med 1991;229:317-23.
14. Radack K, Deck C, Huster G. The comparative effects of n-3 and n-6 polyunsaturated fatty acids on plasma fibrinogen levels: a controlled clinical trial in hypertriglyceridemic subjects. J Am Coll Nutr 1990;9:352-7.
15. Schmidt EB, Pedersen JO, Ekelund S. Cod liver oil inhibits neutrophils and monocyte chemotaxis in healthy males. Atherosclerosis 1989;77:53-7.
16. Lee TH, Hoover RL, Williams JD. Effect of dietary enrichment with eicosapentaenoic and docosahexaenoic acids on in vitro neutrophils and monocyte leukotriene generation and neutrophils function. N Eng J Med 1985;312:1217-24.
17. Endres S, Ghorbani R, Kelley VE. The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N Eng J Med 1989;320:265-71.
18. Li Y, Ferrante A, Poulos A. Neutrophil oxygen radical generation: synergistic responses to tumor necrosis factor and mono/polyunsaturated fatty acids. J Clin Invest 1996;97:1605-9.
19. Terano T, Shiina T, Tamura Y. Eicosapentaenoic acid suppressed the proliferation of vascular smooth muscle cells through modulation of various steps of growth signals. Lipid 1996;31:301-4.
20. Murakami K, Ide T, Suzuki M. Evidence for direct binding of fatty acids and eicosanoids to human peroxisome proliferators-activated receptor alpha. Biochem Biophys Res Commun 1999;260:609-13.
21. Ricote M, Li AC, Wilson TM. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature 1998;391:79-82.
22. Leaf A. The electrophysiologic basis for the antiarrhythmic and anticonvulsant effects of n-3 polyunsaturated fatty acids: heart and brain. Lipids 2001;36:107-10.
23. Scandinavian Simvastatin Survival Study group. Randomized trial of cholesterol lowering in 4,444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344:1383-9.
24. Shepherd J, Cobbe SM, for the West of Scotland Coronary Prevention Study Group. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. New Eng J Med 1995;333:1301-7.
25. Sacks FM, Pfeffer MA, for the Cholesterol and Recurrent Events Trial Investigators. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. New Eng J Med 1996;335:1001-9.
26. The Long-term Intervention with Pravastatin Ischaemic Disease (LIPID) Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. New Eng J Med 1998;339:1349-57.
27. Mataki H, Watsuji Y, Iseki O. Effect of eicosapentaenoic acid in combination with HMG-CoA reductase inhibitor on lipid metabolism. J Intern Med 1998;5:35-6.
28. Nordoy A, Bonaa KH, Nilsen H. Effect of simvastatin and omega-3 fatty acids on plasma lipoproteins and lipid peroxidation in patients with combined hyperlipidaemia. J Intern Med 1998;243:163-70.
29. Nakamura N, Hamazaki T, Ohta M. Joint effect of HMG-CoA reductase inhibitors and eicosapentaenoic acids on serum lipid profile and plasma fatty acid concentrations in patients with hyperlipidemia. Int J Clin Lab Res 1999;29:22-5.
30. Kodama K, Sasaki H, Shimizu Y. Trend of coronary heart disease and its relationship to risk factors in a Japanese population: a 26-year follow-up, Hiroshima/Nagasaki Study. Jpn Circ J 1990;54:414-21.
31. Ross SD, Allen IE, Connelly JE. Clinical outcomes in statin treatment trials: a meta-analysls. Arch Intern Med 1999;159:1793-802.
32. Dolecek TA, Grandits G. Dietary polyunsaturated fatty acids and mortality in the multiple risk factor intervention trial (MRFIT). World Rev Nutr Diet 1991;66:205-16.
33. Shekelle RB, Missell L, Paul O. Fish consumption and mortality from coronary heart disease. New Eng J Med 1985;313:820-1.
34. Nakamura H, for the MEGA STUDY Group. Primary prevention of coronary events with pravastatin in Japanese men and women with mildly or moderately elevated blood cholesterol. J Jpn Atheroscler Soc 1999;26:201-4.
35. Yamamoto A, Horibe H, Mabuchi H. Analysis of serum lipid levels in Japanese men and women: Research Group on Serum Lipid Survey 1990 in Japan. Atherosclerosis 1999;143:55-73.